BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3067796)

  • 1. Compartmentation of glycolysis in trypanosomes: a potential target for new trypanocidal drugs.
    Michels PA
    Biol Cell; 1988; 64(2):157-64. PubMed ID: 3067796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biogenesis of peroxisomes and glycosomes: trypanosomatid glycosome assembly is a promising new drug target.
    Moyersoen J; Choe J; Fan E; Hol WG; Michels PA
    FEMS Microbiol Rev; 2004 Nov; 28(5):603-43. PubMed ID: 15539076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycolysis as a target for the design of new anti-trypanosome drugs.
    Verlinde CL; Hannaert V; Blonski C; Willson M; Périé JJ; Fothergill-Gilmore LA; Opperdoes FR; Gelb MH; Hol WG; Michels PA
    Drug Resist Updat; 2001 Feb; 4(1):50-65. PubMed ID: 11512153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcellular compartmentation of glycolytic intermediates in Trypanosoma brucei.
    Visser N; Opperdoes FR; Borst P
    Eur J Biochem; 1981 Sep; 118(3):521-6. PubMed ID: 7297560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compartmentation of phosphoglycerate kinase in Trypanosoma brucei plays a critical role in parasite energy metabolism.
    Blattner J; Helfert S; Michels P; Clayton C
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11596-600. PubMed ID: 9751711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocation of solutes and proteins across the glycosomal membrane of trypanosomes; possibilities and limitations for targeting with trypanocidal drugs.
    Gualdrón-López M; Brennand A; Avilán L; Michels PA
    Parasitology; 2013 Jan; 140(1):1-20. PubMed ID: 22914253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and activity of inhibitors highly specific for the glycolytic enzymes from Trypanosoma brucei.
    Willson M; Callens M; Kuntz DA; Perié J; Opperdoes FR
    Mol Biochem Parasitol; 1993 Jun; 59(2):201-10. PubMed ID: 8341319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and control of compartmentalized glycolysis in bloodstream form Trypanosoma brucei.
    Bakker BM; Westerhoff HV; Michels PA
    J Bioenerg Biomembr; 1995 Oct; 27(5):513-25. PubMed ID: 8718456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzymes of carbohydrate metabolism as potential drug targets.
    Opperdoes FR; Michels PA
    Int J Parasitol; 2001 May; 31(5-6):482-90. PubMed ID: 11334933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topogenesis of glycolytic enzymes in Trypanosoma brucei.
    Opperdoes FR
    Biochem Soc Symp; 1987; 53():123-9. PubMed ID: 3332763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycolysis and proteases as targets for the design of new anti-trypanosome drugs.
    Lakhdar-Ghazal F; Blonski C; Willson M; Michels P; Perie J
    Curr Top Med Chem; 2002 May; 2(5):439-56. PubMed ID: 11966466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cytosolic and glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei. Kinetic properties and comparison with homologous enzymes.
    Lambeir AM; Loiseau AM; Kuntz DA; Vellieux FM; Michels PA; Opperdoes FR
    Eur J Biochem; 1991 Jun; 198(2):429-35. PubMed ID: 2040304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymes of the trypanothione metabolism as targets for antitrypanosomal drug development.
    Schmidt A; Krauth-Siegel RL
    Curr Top Med Chem; 2002 Nov; 2(11):1239-59. PubMed ID: 12171583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcellular localization of some glycolytic enzymes in parasitic flagellated protozoa.
    Taylor MB; Berghausen H; Heyworth P; Messenger N; Rees LJ; Gutteridge WE
    Int J Biochem; 1980; 11(2):117-20. PubMed ID: 6244201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of topoisomerases in African trypanosomes.
    Shapiro TA
    Acta Trop; 1993 Sep; 54(3-4):251-60. PubMed ID: 7902662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Compartmentation protects trypanosomes from the dangerous design of glycolysis.
    Bakker BM; Mensonides FI; Teusink B; van Hoek P; Michels PA; Westerhoff HV
    Proc Natl Acad Sci U S A; 2000 Feb; 97(5):2087-92. PubMed ID: 10681445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biogenesis of glycosomes of Trypanosoma brucei: an in vitro model of 3-phosphoglycerate kinase import.
    Dovey HF; Parsons M; Wang CC
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2598-602. PubMed ID: 3282231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of SNARE protein Ykt6 in glycosome biogenesis in Trypanosoma brucei.
    Banerjee H; Rachubinski RA
    Mol Biochem Parasitol; 2017 Dec; 218():28-37. PubMed ID: 29107734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glycosomal targets for anti-trypanosomatid drug discovery.
    Barros-Alvarez X; Gualdrón-López M; Acosta H; Cáceres AJ; Graminha MA; Michels PA; Concepción JL; Quiñones W
    Curr Med Chem; 2014; 21(15):1679-706. PubMed ID: 23834165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trypanosomal dUTPases as potential targets for drug design.
    Hidalgo-Zarco F; González-Pazanowska D
    Curr Protein Pept Sci; 2001 Dec; 2(4):389-97. PubMed ID: 12374098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.